Expert Trading Insights

The MTRI Impulsivity Dimension: Fast vs. Reflective Decisions in Trading Our background in behavioral finance has had Traderinsight.com focused on the psychological development of traders for three decades.  It's only a recent evolution that has media outlets like...

Target CEO Change Overshadows Earnings: What Day Traders Should Watch Target posted a slight Q2 beat, but price action says the leadership shift is the real catalyst. Here’s how to trade the reaction—because in the short term, Target CEO change overshadows earnings....

Meme Stock Pump-and-Dump Scams: A Day Trader’s Survival Guide In July, a fresh wave of meme-stock “ramps” rocketed thinly traded microcaps before collapsing just as fast—leaving billions in paper wealth erased and a trail of retail accounts blown up. Here’s what...

Advance Auto Parts (AAP) After Earnings: A Deeper Dive and Day-Trading Playbook Advance Auto Parts posted an EPS beat but guided 2025 lower as interest expense rises following a $1.95B notes offering. The stock’s third straight double-digit post-earnings move makes...

Oracle’s AI Rally Pauses: A Deeper Dive with Day-Trading Setups Oracle (ORCL) slipped more than 4% to ~238 after a torrid June–July run that peaked at 260.87. Price is now decisively below the 21-day moving average while still hovering a few percent above the 50-day,...

The MTRI Neuroticism Dimension in Trading: How Emotional Reactivity Shapes Decisions In our last article, we looked at how the Manz Trader Readiness Inventory can be used as a tool for traders to understand how their psychology affects performance.  Today, we will...

Merck Keytruda Medicare Delay: What It Means for Day Traders The recent tweak to Medicare’s drug price negotiation program has given Merck (MRK) a brief lifeline. While long-term investors are debating whether the change truly softens the looming Keytruda patent...

A Tweak to Medicare is Good for Merck. But Can It Revive the Stock? Merck & Co. has found a small reprieve in Washington, but investors remain skeptical that it will meaningfully alter the company’s trajectory. A new tweak to Medicare’s drug price negotiation...

September Fed Rate Cut: Why Day Traders Should Prepare for a Hawkish Surprise Fed expectations vs. market reality The S&P 500, currently hovering above 6400, has rallied on expectations of a September Fed rate cut. Fed funds futures are pricing an 85% chance of a...

The Manz Trader Readiness Inventory: Measuring Psychological Fitness for Day Trading Success in day trading is about much more than mastering technical setups or memorizing chart patterns. While strategy and execution are essential, they’re only part of the equation....

Intel Government Stake Talks and Day Trading Implications The Trump administration is reportedly considering a 10% equity stake in Intel (INTC), which would convert billions in CHIPS Act funding into ownership. The proposal underscores Washington’s deepening...

Retail Earnings, Tariffs, and Day Trading: Where the Real Risk Lies Why this week matters Headline numbers may look fine; the risk is guidance as retailers speak to the back half (B2S and holiday). Tariff pass-through is the swing factor: modest so far, but price...

Novo Nordisk Wegovy MASH approval: Why NVO is jumping—and how day traders can trade it Quick take Novo Nordisk shares pop after the FDA grants accelerated approval for Wegovy to treat MASH (metabolic dysfunction-associated steatohepatitis) with liver fibrosis in...

DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...

Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...

Zelensky–Trump Meeting Market Impact: What Traders Should Expect As President Volodymyr Zelensky returns to Washington with a cohort of European leaders, the Zelensky–Trump meeting market impact will hinge on three things: the shape of potential security guarantees,...

Big Tech AI Talent War: How Reverse Acquihires Could Reshape Silicon Valley The Big Tech AI talent war is pushing Microsoft, Meta, Google and others to pursue a new playbook—poach founders and core researchers, license the IP, and leave the startup shell behind. It’s...

Disney and Marvel Leaving Georgia: Intraday Stock Action & What It Means for Cleveland What Happened (and Why It Matters) Reports indicate Disney’s Marvel is shifting most big-budget productions away from Georgia and toward the United Kingdom, citing a better...

Trump’s Emerging Market Behavior: Is the US Beginning to Look Like Argentina? For decades, the United States has been the world’s benchmark for financial stability, transparency, and institutional independence. Yet in President Donald Trump’s second term, analysts and...